UPXI:NASDAQUpexi, Inc. Analysis
Data as of 2026-09-02 - not real-time
$1.04
Latest Price
9/10Risk
Risk Level: High
Executive Summary
At $1.04, Upexi, Inc. shows no decisive moving-average alignment, leaving the trend neutral. The last 30 days have gained 20.6%. RSI sits at 57.6, which reads as neutral, and MACD momentum is bullish. Price has been bracketed by support at $0.7000 and resistance at $1.23.
Valuation screens as undervalued: a P/E of 2.0 sits below the sector average of 16.1. The average analyst target implies 25.0% above today's level. Revenue is growing at 44.2%.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 97.0%, a beta of 4.14 and a maximum drawdown of 92.7%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
This one splits by horizon — hold in the near term, buy further out, at 5/10 long-term conviction.
Valuation screens as undervalued: a P/E of 2.0 sits below the sector average of 16.1. The average analyst target implies 25.0% above today's level. Revenue is growing at 44.2%.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 97.0%, a beta of 4.14 and a maximum drawdown of 92.7%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
This one splits by horizon — hold in the near term, buy further out, at 5/10 long-term conviction.
Top Market Events
Taiwan News2monUpexi, Inc. Announces Pricing of ~$19.5 Million Private Placement of Common StockTAMPA, Fla., June 22,...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Trading below the 200-day average of 1.36
- MACD momentum is positive
- 30-day price change of +20.6%
Medium Term
1–3 yearsPositive
Model confidence: 4/10
Key Factors
- P/E of 2.0 versus sector average of 16.1
- Trading below the 200-day average of 1.36
- Analyst targets imply +25.0% versus the current price
Long Term
> 3 yearsPositive
Model confidence: 5/10
Key Factors
- P/E of 2.0 versus sector average of 16.1
- Analyst targets imply +25.0% versus the current price
- Revenue growth of +44.2%
Key Metrics & Analysis
Financial Health
Revenue Growth44.20%
P/E Ratio2.0
ROA-126.53%
P/B Ratio-1.3
Op. Cash Flow$-21524226
Free Cash Flow$-229092160
Industry P/E16.1
Technical Analysis
TrendNeutral
RSI57.6
Support$0.70
Resistance$1.23
MA 20$0.92
MA 50$0.86
MA 200$1.36
MACDBullish
VolumeIncreasing
Fear & Greed Index92.25
Valuation
Target Price$1.30
Upside/Downside25.00%
GradeUndervalued
TypeBlend
Risk Assessment
Beta4.14
Volatility97.03%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.